BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 11795198)

  • 1. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
    Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G
    Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.
    Tetsi L; Charles AL; Paradis S; Lejay A; Talha S; Geny B; Lugnier C
    Cell Mol Life Sci; 2017 May; 74(10):1883-1893. PubMed ID: 28039524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterases: relating structure and function.
    Francis SH; Turko IV; Corbin JD
    Prog Nucleic Acid Res Mol Biol; 2001; 65():1-52. PubMed ID: 11008484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.
    Manganiello VC; Murata T; Taira M; Belfrage P; Degerman E
    Arch Biochem Biophys; 1995 Sep; 322(1):1-13. PubMed ID: 7574662
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seven Dictyostelium discoideum phosphodiesterases degrade three pools of cAMP and cGMP.
    Bader S; Kortholt A; Van Haastert PJ
    Biochem J; 2007 Feb; 402(1):153-61. PubMed ID: 17040207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B; Luong HB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.
    Francis SH; Blount MA; Corbin JD
    Physiol Rev; 2011 Apr; 91(2):651-90. PubMed ID: 21527734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig.
    Johnson WB; Katugampola S; Able S; Napier C; Harding SE
    Life Sci; 2012 Feb; 90(9-10):328-36. PubMed ID: 22261303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC; Hamel LT; Wax MB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide phosphodiesterases in cultured normal and RCS rat pigment epithelium: kinetics of cyclic AMP and cyclic GMP hydrolysis.
    Kurtz MJ; Edwards RB; Schmidt SY
    Exp Eye Res; 1987 Jul; 45(1):67-75. PubMed ID: 2820772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
    J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila cyclic nucleotide phosphodiesterases.
    Davis RL; Kauvar LM
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.